Man Group plc - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Man Group plc ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2023$148,542
+17.1%
16,076
+12.4%
0.00%
Q4 2022$126,841
-78.6%
14,300
-13.2%
0.00%
-100.0%
Q2 2019$592,000
-91.0%
16,484
-90.8%
0.00%
-92.0%
Q1 2019$6,612,000
+28.2%
178,996
+49.5%
0.02%
+8.7%
Q4 2018$5,156,000
+2.4%
119,736
+12.4%
0.02%
+27.8%
Q3 2018$5,033,000
+378.9%
106,548
+404.2%
0.02%
+350.0%
Q2 2018$1,051,00021,1320.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders